New global analysis from the WHO’s International Agency for Research on Cancer further highlights the opportunity to target ...

Investigators reviewed medical literature to determine the prevalence of breast cancer screening among female survivors of a prior cancer other than breast cancer and to compare the likelihood of ...

A total of 30 modifiable risk factors account for almost 40% of new cancer cases globally, a landmark study from the World ...

A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children's cancer has spread at diagnosis in a way ...

Roughly 37–40% of all new cancer cases in 2022—about 7.1 million—were linked to preventable causes, suggesting major ...

The success and popularity of GLP-1 receptor agonists (RAs) for the treatment of patients with diabetes and obesity has led to intense interest in other potential effects of treatment, including ...

Find out more about favourable imaging techniques in mortality rates and early detection among survivors of breast cancer.

A recent WHO analysis estimates that up to 40 per cent of global cancer cases are linked to preventable risk factors such as ...

Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...

Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. A sweeping meta-analysis of over 10,000 studies has found that ...